AgenTus Therapeutics is a dynamic new start-up subsidiary developing T cell receptors (TCRs) and chimeric antigen receptors (CARs) designed to supercharge human immune effector cells to seek and destroy cancer. We aim to deliver cures to cancer patients around the world by leveraging our proprietary platforms for TCR discovery, targeting novel phosphopeptide neo-epitopes and developing unique allogeneic cell therapies. Together with our parent company, Agenus, we have a deep and diverse repertoire of immunotherapy treatments that can be used in combinations that will synergize to help the body’s immune system fight cancer.
Who are we looking for?
What are we looking for?
What are we offering?
The incumbent will be expected to design, execute and analyze complex studies and provide leadership within the program. The incumbent will work with others in a collaborative atmosphere. This will require broad knowledge of current concepts in cancer immunology and associated areas. The individual will present research findings to the group and share expertise with other scientists.
Develop protocols that optimize T cell expansion with specificity for neo-antigens.
Integrate T cell functional assays with TCR discovery team.
Mentor and train Research Associate(s).
Use strong communication skills to interact with other AgenTus scientists and external collaborators.
Read and analyze current scientific literature and integrate knowledge to propose new approaches and areas of study.
Provide critical guidance for platform evaluation and prioritization of potential targets.
Contribute to intellectual property submissions.
Candidates should have the ability to independently troubleshoot technical issues and develop optimized processes and assays for critical tasks. This role has the potential to lead a team of 1-2 research associates.